Progressive multifocal leukoencephalopathy in a patient with undifferentiated systemic vasculitis and bilateral acute retinal necrosis.
Feist
E
E
Stoltenburg-Didinger
G
G
Dörner
T
T
Burmester
G R
GR
Pleyer
U
U
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000956:Antigens, Viral / Q000276:immunology; D000998:Antiviral Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D045586:Intranuclear Inclusion Bodies / Q000473:pathology / Q000821:virology; D007577:JC Virus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D007968:Leukoencephalopathy, Progressive Multifocal / Q000188:drug therapy / Q000473:pathology* / Q000821:virology; D008875:Middle Aged; D019721:Ophthalmoscopes; D010956:Plasmapheresis; D015882:Retinal Necrosis Syndrome, Acute / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D056647:Systemic Vasculitis / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D014775:Virus Activation / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000956:Antigens, Viral; D000998:Antiviral Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents